webinar register page

Neurological Associations of COVID-19: Study results from COPING and CoCo-Neuro.
The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations frequent. In this episode, we will present results from two studies from the UK and France. The COPING study assesses the impact of the novel coronavirus (COVID-19) pandemic on mental and neurological health, and how different factors associated with the virus are affecting the population. The CoCo-Neuro study characterises the neurological and psychiatric manifestations occurring in the context of Covid-19 infection and aims to improve clinical management, rehabilitation and follow-up.

Chair: Prof Tom Solomon, Liverpool Brain Infections Group

Dr Cécile Delorme, Pitié-Salpêtrière Hospital, France: Neuropsychiatric manifestations in patients with Covid-19 : the Pitié-Salpêtrière experience

Professor Gerome Breen, King's College London, United Kingdom: TBC

Brain Infections Global: An NIHR Global Health Research Group on Improving the Management of Acute Brain Infections

Visit: https://braininfectionsglobal.tghn.org/

The Global Health Network's privacy policy: https://braininfectionsglobal.tghn.org/terms/privacy/

Oct 27, 2020 01:00 PM in London

Webinar logo
* Required information

By registering, I agree to the Privacy Statement and Terms of Service.



Prof Tom Solomon
@University of Liverpool, UK
Prof Tom Solomon is Director of the National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections, Head of the Brain Infections Group, Professor of Neurological Science, and Honorary Consultant Neurologist, Walton Centre NHS Foundation Trust and Royal Liverpool University Hospital.
Dr Cécile Delorme
@Pitié-Salpêtrière Hospital, France
Dr Cécile Delorme is a neurology physician in the Department of Neurology of the Pitié-Salpêtrière Hospital in Paris. She received her neurology MD degree from Paris XI University in 2011 and completed a residency in neurology in several hospitals in Paris, followed by a fellowship in the Department of Neurology. She specialized in the field of Movement Disorders, with a particular interest in Deep brain stimulation. During the Covid-19 pandemic in Paris, she was in charge of patients with Covid-19 and neurological symptoms in the hospital. Together with Professor Jean-Yves Delattre and Professor Jean-Christophe Corvol, she led the CoCo-Neurosciences study, an exhaustive cohort of Covid-19 patients with neurological or psychiatric manifestations seen in the Pitié-Salpêtrière and associated hospitals.
Professor Gerome Breen
Professor of Psychiatric Genetics @King's College London
Professor of Psychiatric Genetics in the Social, Genetic and Developmental Psychiatry Centre, at the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. He is a theme lead at the NIHR Biomedical Research Centre at the South London and Maudsley NHS Trust and leads the mental health arm of the overall NIHR BioResource. Within this he leads the Genetic Links to Anxiety and Depression (GLAD; n>24,000). His research spans molecular and bioinformatics studies of psychiatric and neurological disorders and neuropsychiatric/neuropsychology traits. He has published >200 articles on mood disorders, addictions, schizophrenia and eating disorders but has been working throughout the pandemic on the psychiatric and neurological consequences of COVID-19 and the societal response to it in the ~30,000 person COVID-19 Psychiatry and Neurological Genetics (COPING) study in the NIHR BioResource.